Terms: = Prostate cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
142 results:
1. CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds.
Kadry MO; Abdel-Megeed RM
PLoS One; 2024; 19(5):e0302264. PubMed ID: 38723038
[TBL] [Abstract] [Full Text] [Related]
2. CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells.
Liu S; Chen X; Zhang L; Lu B
Cancer Biol Ther; 2024 Dec; 25(1):2329372. PubMed ID: 38494680
[TBL] [Abstract] [Full Text] [Related]
3. The role of polyethylenimine-functionalized gold nanoclusters carrying plasmid CMTM5 in impeding the malignant progression of prostate cancer cells by promoting EGFR endocytosis.
Li L; Li C; Miao F; Chen W; Kong X; Ye R; Feng R
Neoplasma; 2024 Feb; 71(1):48-59. PubMed ID: 38295104
[TBL] [Abstract] [Full Text] [Related]
4. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling.
Zhang E; Chen Z; Liu W; Lin L; Wu L; Guan J; Wang J; Kong C; Bi J; Zhang M
J Transl Med; 2024 Jan; 22(1):12. PubMed ID: 38166947
[TBL] [Abstract] [Full Text] [Related]
5. ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression.
Xu H; Li YF; Yi XY; Zheng XN; Yang Y; Wang Y; Liao DZ; Zhang JP; Tan P; Xiong XY; Jin X; Gong LN; Qiu S; Cao DH; Li H; Wei Q; Yang L; Ai JZ
Mil Med Res; 2023 Dec; 10(1):64. PubMed ID: 38082365
[TBL] [Abstract] [Full Text] [Related]
6. Integrative bioinformatics analysis of biomarkers and pathways for exploring the mechanisms and molecular targets associated with pyroptosis in type 2 diabetes mellitus.
Wang W; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1207142. PubMed ID: 38034011
[TBL] [Abstract] [Full Text] [Related]
7. LRP5 competes for SPOP binding to enhance tumorigenesis mediated by Daxx and PD-L1 in prostate cancer.
Gan S; Qu F; Zhang X; Pan X; Xu D; Cui X; Hou J
Exp Cell Res; 2024 Jan; 434(1):113857. PubMed ID: 38008278
[TBL] [Abstract] [Full Text] [Related]
8. FOXS1 promotes prostate cancer progression through the Hedgehog/Gli1 pathway.
Wang M; Huang W
Biochem Pharmacol; 2023 Dec; 218():115893. PubMed ID: 37890593
[TBL] [Abstract] [Full Text] [Related]
9. P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.
Zhang M; Kan D; Zhang B; Chen X; Wang C; Chen S; Gao W; Yang Z; Li Y; Chen Y; Zhu S; Wen S; Niu Y; Shang Z
J Exp Clin Cancer Res; 2023 Aug; 42(1):215. PubMed ID: 37599359
[TBL] [Abstract] [Full Text] [Related]
10. TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination.
Zhou Q; Chen X; Yao K; Zhang Y; He H; Huang H; Chen H; Peng S; Huang M; Cheng L; Zhang Q; Xie R; Li K; Lin T; Huang H
J Exp Clin Cancer Res; 2023 Aug; 42(1):195. PubMed ID: 37542345
[TBL] [Abstract] [Full Text] [Related]
11. PSMC4 promotes prostate carcinoma progression by regulating the CBX3-EGFR-PI3K-AKT-mTOR pathway.
Liu K; Zhang S; Gong Y; Zhu P; Shen W; Zhang Q
J Cell Mol Med; 2023 Aug; 27(16):2437-2447. PubMed ID: 37436074
[TBL] [Abstract] [Full Text] [Related]
12. A rare case of prostate cancer initially presented by disseminated intravascular coagulation-related subdural hemorrhage.
Shafie M; Shahmohamadi E; Hadizadeh A; Hasanzadeh A; Gholampour G; Parsa S
Cancer Rep (Hoboken); 2023 Sep; 6(9):e1868. PubMed ID: 37435692
[TBL] [Abstract] [Full Text] [Related]
13. PARP1 negatively regulates transcription of BLM through its interaction with HSP90AB1 in prostate cancer.
Huang M; Chen L; Guo Y; Ruan Y; Xu H
J Transl Med; 2023 Jul; 21(1):445. PubMed ID: 37415147
[TBL] [Abstract] [Full Text] [Related]
14. Bony structure enhanced synthetic CT generation using Dixon sequences for pelvis MR-only radiotherapy.
Liang X; Yen A; Bai T; Godley A; Shen C; Wu J; Meng B; Lin MH; Medin P; Yan Y; Owrangi A; Desai N; Hannan R; Garant A; Jiang S; Deng J
Med Phys; 2023 Dec; 50(12):7368-7382. PubMed ID: 37358195
[TBL] [Abstract] [Full Text] [Related]
15. Update on Adjustable Trans-Obturator Male System (ATOMS) for Male Incontinence after prostate cancer Surgery.
Téllez C; Szczesniewski J; Virseda-Chamorro M; Arance I; Angulo JC
Curr Oncol; 2023 Apr; 30(4):4153-4165. PubMed ID: 37185429
[TBL] [Abstract] [Full Text] [Related]
16. First in man study: Bcl-Xl_42-CAF
Mørk SK; Kongsted P; Westergaard MCW; Albieri B; Granhøj JS; Donia M; Martinenaite E; Holmström MO; Madsen K; Kverneland AH; Kjeldsen JW; Holmstroem RB; Lorentzen CL; Nørgaard N; Andreasen LV; Wood GK; Christensen D; Klausen MS; Hadrup SR; Thor Straten P; Andersen MH; Svane IM
Front Immunol; 2023; 14():1122977. PubMed ID: 36999039
[TBL] [Abstract] [Full Text] [Related]
17. Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer.
Kong D; Ye C; Zhang C; Sun X; Wang F; Chen R; Xiao G; He S; Xu J; Rao X; Ai J; Gao X; Li H; Su L
J Exp Clin Cancer Res; 2023 Feb; 42(1):45. PubMed ID: 36759880
[TBL] [Abstract] [Full Text] [Related]
18. Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m
Zhao Y; Wen S; Li H; Pan CW; Wei Y; Huang T; Li Z; Yang Y; Fan S; Zhang Y
Theranostics; 2023; 13(2):596-610. PubMed ID: 36632223
[No Abstract] [Full Text] [Related]
19. SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination.
Lv T; He D; Zhang X; Guo X; Li Z; Zhang A; Fan B; Wang Z
Aging (Albany NY); 2022 Dec; 14(24):10050-10066. PubMed ID: 36566018
[TBL] [Abstract] [Full Text] [Related]
20. Hsa_circ_0094606 promotes malignant progression of prostate cancer by inducing M2 polarization of macrophages through PRMT1-mediated arginine methylation of ILF3.
Zhang Y; Wang K; Yang D; Liu F; Xu X; Feng Y; Wang Y; Zhu S; Gu C; Sheng J; Hu L; Xu B; Lu YJ; Feng N
Carcinogenesis; 2023 May; 44(1):15-28. PubMed ID: 36394342
[TBL] [Abstract] [Full Text] [Related]
[Next]
